Location: San Francisco, CA
CIK: 0001587114 · Show all filings
Period: Q1 2023 (← Previous) (Next →)
Filing Date: May 15, 2023
Total Value: $3.105B (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| PRTA | PROTHENA CORP PLC | 11,584,280 | $561M | 18.1% | $11.63 | +354.1% | SHS | G72800108 |
| SRPT | SAREPTA THERAPEUTICS INC | 2,999,453 | $413M | 13.3% | $76.84 | +68.8% | COM | 803607100 |
| APLS | APELLIS PHARMACEUTICALS INC | 5,451,647 | $360M | 11.6% | $41.28 | +39.8% | COM | 03753U106 |
| GLPG | GALAPAGOS NV | 4,244,645 | $164M | 5.3% | $52.43 | — | SPON ADR | 36315X101 |
| ANAB | ANAPTYSBIO INC | 7,521,024 | $164M | 5.3% | $23.15 | +5.0% | COM | 032724106 |
| XNCR | XENCOR INC | 5,282,516 | $147M | 4.7% | $33.50 | -8.0% | COM | 98401F105 |
| — | MORPHIC HLDG INC | 3,846,966 | $145M | 4.7% | $29.75 | — | COM | 61775R105 |
| RVMD | REVOLUTION MEDICINES INC | 5,352,183 | $116M | 3.7% | $21.45 | +14.8% | COM | 76155X100 |
| ACAD | ACADIA PHARMACEUTICALS INC | 5,991,479 | $113M | 3.6% | $22.11 | -13.9% | COM | 004225108 |
| ARVN | ARVINAS INC | 3,717,788 | $102M | 3.3% | $54.94 | -42.5% | COM | 04335A105 |
| ZYME | ZYMEWORKS INC | 10,087,473 | $91.19M | 2.9% | $7.45 | +17.1% | COM | 98985Y108 |
| — | SPRINGWORKS THERAPEUTICS INC | 3,460,208 | $89.07M | 2.9% | $28.53 | — | COM | 85205L107 |
| KURA | KURA ONCOLOGY INC | 6,638,371 | $81.19M | 2.6% | $18.76 | -33.5% | COM | 50127T109 |
| RLAY | RELAY THERAPEUTICS INC | 4,163,824 | $68.58M | 2.2% | $28.03 | -36.0% | COM | 75943R102 |
| JANX | JANUX THERAPEUTICS INC | 3,838,486 | $46.45M | 1.5% | $18.73 | -11.1% | COM | 47103J105 |
| VYGR | VOYAGER THERAPEUTICS INC | 3,851,507 | $29.7M | 1.0% | $3.51 | — | COM | 92915B106 |
| DYN | DYNE THERAPEUTICS INC | 2,322,384 | $26.75M | 0.9% | $11.57 | +12.2% | COM | 26818M108 |
| — | NGM BIOPHARMACEUTICALS INC | 6,435,518 | $26.26M | 0.8% | $5.88 | — | COM | 62921N105 |
| ALEC | ALECTOR INC | 4,056,548 | $25.11M | 0.8% | $19.56 | -58.4% | COM | 014442107 |
| KYMR | KYMERA THERAPEUTICS INC | 796,093 | $23.59M | 0.8% | $26.36 | +22.4% | COM | 501575104 |
| EWTX | EDGEWISE THERAPEUTICS INC | 3,493,194 | $23.3M | 0.8% | $18.91 | -51.0% | COM | 28036F105 |
| NUVB | NUVATION BIO INC | 13,896,543 | $23.07M | 0.7% | $11.16 | -81.8% | COM CL A | 67080N101 |
| ALLO | ALLOGENE THERAPEUTICS INC | 4,488,200 | $22.17M | 0.7% | $8.88 | -27.8% | COM | 019770106 |
| CNTA | CENTESSA PHARMACEUTICALS PLC | 5,618,779 | $21.63M | 0.7% | $4.55 | — | SPONSORED ADS | 152309100 |
| CRNX | CRINETICS PHARMACEUTICALS IN | 1,330,263 | $21.36M | 0.7% | $22.08 | -16.2% | COM | 22663K107 |
| — | GRAPHITE BIO INC | 8,538,446 | $20.92M | 0.7% | $3.82 | — | COM | 38870X104 |
| AVIR | ATEA PHARMACEUTICALS INC | 6,184,861 | $20.72M | 0.7% | $14.25 | -71.5% | COM | 04683R106 |
| — | ADICET BIO INC | 3,560,700 | $20.51M | 0.7% | $8.94 | — | COM | 007002108 |
| ORIC | ORIC PHARMACEUTICALS INC | 3,418,068 | $19.48M | 0.6% | $30.24 | -82.7% | COM | 68622P109 |
| TNGX | TANGO THERAPEUTICS INC | 4,201,414 | $16.6M | 0.5% | $6.32 | -8.2% | COM | 87583X109 |
| OVID | OVID THERAPEUTICS INC | 6,117,400 | $15.78M | 0.5% | $3.32 | -28.6% | COM | 690469101 |
| — | CHINOOK THERAPEUTICS INC | 445,550 | $10.31M | 0.3% | $16.36 | — | COM | 16961L106 |
| — | GENERATION BIO CO | 1,956,579 | $8.413M | 0.3% | $4.30 | — | COM | 37148K100 |
| — | POSEIDA THERAPEUTICS INC | 2,650,000 | $8.162M | 0.3% | $3.53 | — | COM | 73730P108 |
| — | THIRD HARMONIC BIO INC | 1,802,122 | $7.425M | 0.2% | $4.12 | — | COM | 88427A107 |
| PRME | PRIME MEDICINE INC | 600,000 | $7.38M | 0.2% | $18.06 | -9.8% | COM | 74168J101 |
| PRQR | PROQR THRAPEUTICS N V | 2,902,715 | $6.183M | 0.2% | $3.06 | 0.0% | SHS EURO | N71542109 |
| BEAM | BEAM THERAPEUTICS INC | 198,591 | $6.081M | 0.2% | $39.47 | 0.0% | COM | 07373V105 |
| ARQT | ARCUTIS BIOTHERAPEUTICS INC | 415,322 | $4.569M | 0.1% | $16.92 | -14.5% | COM | 03969K108 |
| MGNX | MACROGENICS INC | 619,192 | $4.44M | 0.1% | $4.10 | +46.8% | COM | 556099109 |
| — | ALIGOS THERAPEUTICS INC | 3,948,360 | $3.451M | 0.1% | $2.37 | — | COM | 01626L105 |
| CGEM | CULLINAN ONCOLOGY INC | 246,410 | $2.521M | 0.1% | $11.34 | -2.8% | COM | 230031106 |
| — | TEMPEST THERAPEUTICS INC | 1,031,268 | $2.393M | 0.1% | $2.15 | — | COM | 87978U108 |
| BDTX | BLACK DIAMOND THERAPEUTICS I | 1,191,094 | $2.251M | 0.1% | $2.18 | +5.4% | COM | 09203E105 |
| — | SURFACE ONCOLOGY INC | 3,082,959 | $2.154M | 0.1% | $2.94 | — | COM | 86877M209 |
| ERAS | ERASCA INC | 678,441 | $2.042M | 0.1% | $20.63 | -82.4% | COM | 29479A108 |
| — | EUCRATES BIOMEDICAL ACQU COR | 200,000 | $2.028M | 0.1% | $9.98 | — | SHS | G3141W106 |
| — | HOOKIPA PHARMA INC | 2,473,489 | $1.82M | 0.1% | $2.28 | — | COM | 43906K100 |
| — | NUVATION BIO INC | 963,333 | $1.599M | 0.1% | $10.45 | — | *W EXP 07/07/202 | 67080N119 |
| — | GRACELL BIOTECHNOLOGIES INC | 798,948 | $1.486M | 0.0% | $2.66 | — | SPONSORED ADS | 38406L103 |
| NAMSW | NEWAMSTERDAM PHARMA COMPANY | 66,665 | $884K | 0.0% | $10.90 | — | *W EXP 11/22/202 | N62509117 |
| — | EUCRATES BIOMEDICAL ACQU COR | 66,666 | $676K | 0.0% | $9.90 | — | *W EXP 10/23/202 | G3141W122 |
| — | KRONOS BIO INC | 326,780 | $477K | 0.0% | $29.87 | — | COM | 50107A104 |
| — | SELECTA BIOSCIENCES INC | 200,000 | $278K | 0.0% | $1.31 | — | COM | 816212104 |
| — | CAREMAX INC | 100,000 | $267K | 0.0% | $12.90 | — | *W EXP 06/08/202 | 14171W111 |
| — | CYTEIR THERAPEUTICS INC | 43,823 | $79,758 | 0.0% | $1.82 | — | COM | 23284P103 |
| SRZNW | SURROZEN INC | 66,665 | $40,132 | 0.0% | $7.07 | — | *W EXP 08/01/203 | 86889P117 |
| — | ITEOS THERAPEUTICS INC | 1,300 | $17,693 | 0.0% | $21.93 | — | COM | 46565G104 |